Holly Lindsay

Center for Cancer and Blood Disorders — United States

Medicine · Health Sciences

19h-index1.2kcitations164works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(108), Neuroblastoma Research and Treatments(35), Cancer Research and Treatments(27), Cancer, Hypoxia, and Metabolism(14), Chromatin Remodeling and Cancer(10)

Publications163 total

A Quality Improvement Initiative: Increasing Awareness of Long-Term Follow-Up Care in Pediatric Cancer Survivors and Caregivers
Journal of Pediatric Hematology/Oncology·2026
A Phase 1 Trial of Fimepinostat in Children and Adolescents With Relapsed and Refractory Solid and <scp>CNS</scp> Tumors
Cancer Medicine·2025· 1 citedOpen Access
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science
UNC Libraries·2025Open Access
Detecting childhood trauma in MDD patients through automated speech and language analysis
European Psychiatry·2025Open Access
Objective Measures of Stress: Association of Speech Features and Cortisol
European Psychiatry·2025Open Access
Supplementary Table S4 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025Open Access
Supplementary Figure S2 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025Open Access
Supplementary Table S3 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025Open Access
Data from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025Open Access
Supplementary Figure S1 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025Open Access
Supplementary Data S1 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025Open Access
Supplementary Table S5 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025Open Access
Supplementary Table S1 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025Open Access
Supplementary Table S2 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025Open Access
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
Clinical Cancer Research·2024· 10 citedOpen Access
Toxicity profile of high‐dose methotrexate in young children with central nervous system tumors
Pediatric Blood & Cancer·2024· 4 citedOpen Access
The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma
Neuro-Oncology·2024· 3 citedOpen Access
TRLS-06. PHASE 1 STUDY OF THE CD40 AGONISTIC MONOCLONAL ANTIBODY APX005M (SOTIGALIMAB) IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT PATIENTS WITH RECURRENT OR PROGRESSIVE CNS TUMORS AND NEWLY DIAGNOSED BRAIN STEM GLIOMA: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC-051; NCT03389802)
Neuro-Oncology·2024· 2 citedOpen Access
PALC-03. MEDICAL AID IN DYING: EXPERIENCE IN THE CENTER FOR CANCER AND BLOOD DISORDERS AT CHILDREN’S HOSPITAL COLORADO
Neuro-Oncology·2024Open Access
EPEN-24. 5FU SENSITIVITY IS MEDIATED THROUGH TRISOMY UCK2 EXPRESSION IN 1Q+ PFA EPN
Neuro-Oncology·2024Open Access
page 1 of 9Next →

Frequent Co-authors

Xiao‐Nan Li(18), Patricia Baxter(16), Frank Braun(15), Huiyuan Zhang(14), Sibo Zhao(14), Mari Kogiso(13), Yuchen Du(12), Lin Qi(11), Murali Chintagumpala(11), D. Williams Parsons(10), Adekunle M. Adesina(9), Yulun Huang(8), Frank Y. Lin(7), Wan‐Yee Teo(7), László Perlaky(7), Jason Fangusaro(6), Sarah G. Injac(6), Jo Lynne Rokita(5), Sharon J. Diskin(5), Olena M. Vaske(5)